[Pharmacological and clinico-pharmacological studies of a combination preparation for calves having antianemia and general tonic action].
A combined preparation, biofer, was studied, defining its clinical and pharmacological capacity. Featuring in its composition are: normal bovine gammaglobulin, 8.0 g; ferridextran (dextrofer-100), 32 cm2 (= 3.2 g Fe); cuprum sulfuricum, 0.32 g (= 0.08 Cu); Co chloride, 0.18 g (= 0.08 Co); cyancobalamin, 0.0032 g; and protein hydrolysate up to 100 cm3, at pH = 7.0-7.2. The local and total tolerance of animals for biofer was studied along with the acute toxicity, absorption, and retention in the body of test animals and calves as well as the antianemic action in albino mice and calves. It was found that at 4 degrees C to 8 degrees C the shelf life of biofer was 2 years. Its LD50 at subcutaneous injection to albino rats was 11.7 cm3/kg body mass. At the rate of 0.6 cm3/kg (i/m) rabbits did not manifest local and total intolerance; at 1.8 cm3/kg there was no local inflammation, however, a transient drop of appetite was seen; at 3 cm3/kg rabbits manifested intoxication with exitus. At i/m introduction to rabbits and calves biofer was more slowly absorbed than dextrofer-100. The liver and spleen of animals injected with biofer showed higher values for copper. In i/m application to anemic albino rats biofer showed a better antianemic effect than dextrofer-100. In calves it activated to a better extent both erythropoiesis and leukopoiesis.
D000042:Absorption; D000740:Anemia / Q000188:drug therapy / Q000662:veterinary*; D000818:Animals; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy*; D003035:Cobalt / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D003300:Copper / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D019327:Copper Sulfate; D004338:Drug Combinations / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D004341:Drug Evaluation / Q000662:veterinary; D004353:Drug Evaluation, Preclinical / Q000662:veterinary; D004361:Drug Tolerance; D005296:Ferrous Compounds; D007505:Iron-Dextran Complex / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D008297:Male; D051379:Mice; D011492:Protein Hydrolysates / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D051381:Rats; D011919:Rats, Inbred Strains; D014805:Vitamin B 12 / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D005719:gamma-Globulins / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity
D004338:Drug Combinations; D005296:Ferrous Compounds; D011492:Protein Hydrolysates; D005719:gamma-Globulins; C020748:ferrous sulfate; D003035:Cobalt; D003300:Copper; D007505:Iron-Dextran Complex; C018021:cobaltous chloride; D019327:Copper Sulfate; D014805:Vitamin B 12
Kombiniran preparat za teleta s protivoanemichno i obshtoukrepvashto deĭstvie--farmakologichni i kliniko-farmakologichni izsledvaniia.